ALK and lung cancer: Furthermore, we are able to recapitulate in wild type mice the effects of crizotinib treatment in lung cancer patients, as inhibition of ALK activity by crizotinib treatment results in a reduction of testosterone levels in adult wild type male mice, as has been observed in crizotinib treated male patients.